基础医学与临床 ›› 2023, Vol. 43 ›› Issue (2): 252-258.doi: 10.16352/j.issn.1001-6325.2023.02.252

• 研究论文 • 上一篇    下一篇

咪达唑仑减轻缺氧/复氧诱导的小鼠海马神经元损伤

魏健强1, 张春瑞2*   

  1. 1.延安大学附属医院 神经血管介入治疗中心, 陕西 延安 716000;
    2.汉中市人民医院 神经内科, 陕西 汉中 723000
  • 收稿日期:2022-04-27 修回日期:2022-07-21 出版日期:2023-02-05 发布日期:2023-02-02
  • 通讯作者: *zhangchunrui99@163.com
  • 基金资助:
    国家自然科学基金(81701207)

Midazolam attenuates hypoxia-reoxygenation-induced neuronal injury in mouse hippocampus

WEI Jianqiang1, ZHANG Chunrui2*   

  1. 1. Neurovascular Interventional Therapy Center, the Affiliated Hospital of Yan'an University, Yan'an 716000;
    2. Department of Neurology, Hanzhong People's Hospital, Hanzhong 723000, China
  • Received:2022-04-27 Revised:2022-07-21 Online:2023-02-05 Published:2023-02-02
  • Contact: *zhangchunrui99@163.com

摘要: 目的 探讨咪达唑仑基于丝裂原活化蛋白激酶(MAPK)/核转录因子-κB(NF-κB)信号通路对缺氧/复氧诱导的神经元损伤的影响。方法 体外培养小鼠海马神经元,MTT法检测0、5、10、40、70和100 ng/mL咪达唑仑对其缺氧/复氧后细胞活力的影响,筛选出最佳作用浓度。将培养的小鼠海马神经元随机分为对照组、模型组(缺氧3 h再复氧12 h)、咪达唑仑(70 ng/mL)组、C16-PAF(MAPK激活剂,4 μmol/L)组、咪达唑仑(70 ng/mL)+C16-PAF组(4 μmol/L),通过Hoechst33258染色和流式细胞检测神经元凋亡情况;ELISA测量细胞乳酸脱氢酶(LDH)、肿瘤坏死因子-α(TNF-α)、白细胞介素-18(IL-18)、白细胞介素-17(IL-17)释放量及细胞超氧化物歧化酶(SOD)、过氧化氢酶(CAT)活性;免疫印迹检测细胞凋亡蛋白及MAPK/NF-κB通路蛋白表达。结果 与对照组比较,模型组神经元凋亡率、LDH释放量、MAPK/NF-κB通路p-p38 MAPK/p38 MAPK、p-NF-κB p65/NF-κB p65水平明显升高(P<0.05)。与模型组、咪达唑仑+C16-PAF组分别比较,咪达唑仑组神经元凋亡率、LDH释放量、MAPK/NF-κB通路p-p38 MAPK/p38 MAPK、p-NF-κB p65/NF-κB p65水平均降低(P<0.05);C16-PAF组神经元凋亡率、LDH释放量、MAPK/NF-κB通路p-p38 MAPK/p38 MAPK、p-NF-κB p65/NF-κB p65水平均升高(P<0.05)。结论 咪达唑仑可能通过抑制MAPK/NF-κB信号激活降低炎性细胞因子表达,进而抑制缺氧/复氧诱导的炎性和氧化应激反应,减轻神经元损伤,降低其凋亡率。

关键词: 咪达唑仑, 丝裂原活化蛋白激酶/核转录因子-κB, 缺氧/复氧, 神经元, 损伤

Abstract: Objective To investigate the impact of midazolam on hypoxia-reoxygenation-induced neuronal injury based on mitogen-activated protein kinase (MAPK)/nuclear factor-κB (NF-κB) signaling pathway. Methods Mouse hippocampus neurons were cultured in vitro and the effects of 0, 5, 10, 40, 70 and 100 ng/mL midazolam on cell viability after hypoxia and reoxygenation were detected by MTT assay, and the best concentration was screened out. The cultured mouse hippocampus neurons were randomly separated into control group, model group (anoxic for 3 hours and reoxygenated for 12 hours), midazolam (70 ng/mL) group, C16-PAF (MAPK activator, 4 μmol/L) group, and midazolam (70 ng/mL) + C16-PAF group (4 μmol/L). The apoptosis of neurons was detected by Hoechst33258 staining and flow cytometry; the releases of lactate dehydrogenase (LDH), tumor necrosis factor-α(TNF-α), interleukin-18 (IL-18), and interleukin-17 (IL-17) and the levels of cellular superoxide dismutase (SOD) and catalase (CAT) were detected by ELISA; the expression of apoptosis proteins and MAPK/NF-κB pathway proteins were detected by western blotting. Results Compared with the control group, the neuron apoptosis rate, LDH, the TNF-α, IL-18, IL-17 releases, apoptosis protein caspase-9, Bax expression, and MAPK/NF-κB pathway p-p38 MAPK/p38 MAPK and p-NF-κB p65/NF-κB p65 levels were significantly increased in the model group (P<0.05), the CAT and SOD levels in cells were significantly decreased (P<0.05). Compared with the model group and midazolam+C16-PAF group, the neuron apoptosis rate, LDH, the TNF-α, IL-18, IL-17 releases, apoptosis protein caspase-9, Bax expression, and MAPK/NF-κB pathway p-p38 MAPK/p38 MAPK and p-NF-κB p65/NF-κB p65 levels were significantly decreased in the midazolam group (P<0.05), the CAT and SOD activity in cells were significantly increased (P<0.05); the neuron apoptosis rate, LDH, the TNF-α, IL-18, IL-17 releases, apoptosis protein caspase-9, Bax expression, and MAPK/NF-κB pathway p-p38 MAPK/p38 MAPK and p-NF-κB p65/NF-κB p65 levels were significantly increased in the C16-PAF group(P<0.05), the CAT and SOD levels in cells were significantly decreased (P<0.05). Conclusions Midazolam can reduce the expression of inflammatory cytokines by inhibiting the activation of MAPK/NF-κB signaling, thereby inhibiting the inflammatory and oxidative stress responses induced by hypoxia and reoxygenation, reducing neuronal cell damage and its apoptosis rate.

Key words: midazolam, mitogen-activated protein kinase/nuclear transcription factor-κB, hypoxia and reoxygenation, neuron, injury

中图分类号: